For patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.
Kathleen Wilson, MPH
Advertisement
Articles by Kathleen Wilson, MPH
Advertisement
Latest Updated Articles
- Etanercept and Ustekinumab Dosing for Psoriasis and Psoriatic Arthritis
September 21st 2017
Advertisement
Advertisement
Trending on Pharmacy Times
1
Cyclosporiasis Cases Reach 5100: Investigators Zero in on Lettuce, Possible Taco Bell Link
2
Anemia in Multiple Myeloma: Mechanisms, Management, and Emerging Therapies
3
Gedatolisib Combination Approved for PIK3CA Wild-Type HR+, HER2– Breast Cancer
4
FDA Grants Traditional Approval to Selpercatinib for RET Fusion-Positive Solid Tumors Across Multiple Cancer Types
5